Author

S.-Y.M. Liu

Observed names: Shuyin Liu, Sinyi Liu

Institution: Jinan University

Observed institutions: Jinan University, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, First Affiliated Hospital of Jinan University, University of Birmingham

OpenAlex ID: A5065482196

Maladaptive Neuroplasticity Under Stress: Insights into Neuronal and Synaptic Changes in the Prefrontal Cortex

2025 · Bingyu Ren, Quan Yuan, et al. · Molecular Neurobiology · 23

P3.08F.02 MRD Guiding Treatment after Aumolertinib Induction Therapy for EGFRm+ Stage III NSCLC in the MDT Diagnostic Model (APPROACH)

2024 · Q. Zhou, Y. Pan, et al. · Journal of Thoracic Oncology · 3

LBA2 Phase II study of PD-L1 expression guidance on neoadjuvant (NA) nivolumab (Nivo) monotherapy with or without platinum-doublet chemotherapy in resectable NSCLC

2022 · S.-Y. Liu, S. Dong, et al. · Immuno-Oncology Technology · 3

P1.06B.14 Optimal Cut-Off with NGS for Metamplification Andclinical Relevance to MET Inhibitor in Non-Small-Cell Lung Cancer

2024 · S.-Y.M. Liu, Z. Xie, et al. · Journal of Thoracic Oncology · 1

WS02.13 PD-L1 Expression Guidance on Sintilimab versus Pembrolizumab in Untreated Advanced NSCLC (CTONG1901)

2023 · S.-Y.M. Liu, J.-Y. Deng, et al. · Journal of Thoracic Oncology · 1

MA07.08 Proteogenomic Analysis of CSF Reveals Distinct Molecular Patterns of Leptomeningeal Metastases in EGFR-Mutated NSCLC

2024 · M.-M. Zheng, S.-H. Lin, et al. · Journal of Thoracic Oncology

P4.11E.16 Clinical Outcome of HER2-mut NSCLC Treated with First-Line Immunotherapy-Based Regimens versus Chemotherapy/HER2-TKIs

2024 · K. Yin, L.-P. Chen, et al. · Journal of Thoracic Oncology

P4.11E.12 First Line Camrelizumab for Brain Metastases of NSCLC (CTONG 2003): A Randomized Controlled Trial

2024 · Y.-S. Li, J.-J. Yang, et al. · Journal of Thoracic Oncology

P1.08B.01 Predicting Tumor Recurrence Risk in Locally Advanced NSCLC with Detectable ctDNA-Based Molecular Residual Disease: An Xgboost Model Analysis

2024 · Y. Pan, J.-T. Zhang, et al. · Journal of Thoracic Oncology

Impact of Green Policies on Industrial Upgrading

2024 · Shuyin Liu

P2.06-07 PD-L1 Expression Guidance on Sintilimab versus Pembrolizumab in Untreated Advanced NSCLC (CTONG1901)

2023 · S.-Y.M. Liu, J.-Y. Deng, et al. · Journal of Thoracic Oncology

Works count: 11

Citation count: 31

H-index: 3

I10-index: 1